Subscribe to Search results

Funding was agreed and a commencement for HCV testing in July was likely.

Published on:

At an East Anglia Blood Transfusion Centre meeting, Professor Allain said he would prefer to introduce routine testing at an early date.

Published on:

At a meeting of the NBTS' Northern Division, Dr Gunson described extending the original valuation study.

Published on:

Dr Gunson presented the results of the pilot study to a meeting of the National Management Committee of the NBTS and undertook to prepare a more comprehensive report for the ACVSB.

Published on:

Professor Zuckerman spoke of a specific test for non-A non-B Hepatitis being "awaited with breathless anticipation", thereby conveying both the importance of developing such a test and the urgency of doing so.

Published on:

The Ortho assay was published in "Science" and was evaluated internationally from that date onwards.

Published on:

"The Lancet" carried two letters on the topic of "Screening for Hepatitis C Virus Antibody", the first from Dr Contreras and Dr Barbara and the second from Professor Cash.

Published on:

Dr Barbara went to the Paris meeting and regarded the test as "reproducible, robust and meaningful".

Published on:

Brown and Thomas published "Blood Transfusion Services Should Have Begun Screening for Hepatitis C When an Antibody Assay First Became Available" in "Reviews in Medical Virology".

Published on:

Dr Lloyd wrote to Professor Cash reiterating his concern that the UK was "dragging its feet over testing" and was running the risk of "accepting the lowest common denominator" approach.

Published on:

The full report for the multi-centre study on non-A non-B Hepatitis surrogate screening was eventually completed in April 1990.

Published on:

Anti-HCV testing was to begin on 1 September 1991.

Published on:

In the mid to late 1980s in the US, the incidence of non-A non-B Hepatitis was 7-12%.

Published on:

The "line to take" included "UK blood is still considered one of the safest in the world, and we continue to investigate ways of making it safer still" and "The prevalence of Hepatitis C in the population in this country has not been established, nor has the role of blood in its transmission."

Published on:

Professor John Cash asked Dr Ginger Rosenberg at Chiron for access in due course to antibody testing kits for evaluation purposes.

Published on:

Robert Panton requested funding for the pilot study.

Published on:

Ortho organised a meeting in London with representatives from both the English and Scottish blood services to look at the preliminary UKBTS data.

Published on:

It was "important that the UK Blood Transfusion Services should act in unison on this subject" of HCV testing.

Published on:

Dr Lloyd reiterated his concern that the UK was "dragging its feet over testing" and was running the risk of "accepting the lowest common denominator" approach.

Published on:

Dr Boulton insisted that the screening of donors for HCV antibodies should be introduced at the earliest possible opportunity.

Published on: